Recalls / Class II
Class IID-1271-2019
Product
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019
- Affected lot / code info
- Lot: 190212AB BUD: 5/13/2019
Why it was recalled
Defective Delivery System: difficult to express
Recalling firm
- Firm
- Pacifico National, Inc. dba AmEx Pharmacy
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 1515 Elizabeth St Ste J, N/A, Melbourne, Florida 32901-3000
Distribution
- Quantity
- 249 syringes
- Distribution pattern
- Nationwide in the US
Timeline
- Recall initiated
- 2019-04-19
- FDA classified
- 2019-05-07
- Posted by FDA
- 2019-05-08
- Terminated
- 2021-02-16
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1271-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.